Skip to main content
. 2021 Apr 27;27(8):1158–1166. doi: 10.1016/j.cmi.2021.04.010

Table 2.

Patient outcomes in all eligible patients and in the cohort of patients having filled the medical questionnaire by type of PCR results (positive, negative, untested)

All eligible patients (n = 43 103) Eligible patients with a completed medical questionnaire (n = 29 104) Medical questionnaire and positive PCR (n = 7320) Medical questionnaire and negative PCR (n = 5281) Medical questionnaire and no PCR result (n = 16 503)
Clinical worsening 1751 (4.1%; 95% CI 3.9−4.2) 1124 (3.9%; 95% CI 3.6−4.1) 659 (9.0%; 95% CI 8.3−9.7) 239 (4.5%; 95% CI 4.0−5.1) 226 (1.4%; 95% CI 1.2−1.5)
Patient outcomea
Hospitalized 1728 (4.0%; 95% CI 3.8−4.2) 1121 (3.9%; 95% CI 3.6−4.1) 659 (9.0%; 95% CI 8.3−9.7) 239 (4.5%; 95% CI 4.0−5.1) 223 (1.4%; 95% CI 1.2−1.5)
Deceased 64 (0.1%; 95% CI 0.1−0.2) 6 (0.02%; 95% CI 0.00−0.04) 3 (0.04%; 95% CI 0.01−0.09) 0 (0.00%; 95% CI 0.00−0.00) 3 (0.02%; 95% CI 0.00−0.04)
a

The sum of the categories can exceed the total number of patients having experienced a clinical worsening as some were included in more than one category.